Products

New animal model development

For more than a decade we have developed and validated new animal models, primarily on transgenic mice carrying human molecular markers for novel therapeutic approaches. We have developed and validated preclinical animal models for

• Psoriasis
• Osteoporosis
• Rheymatiod Arthritis
• Spondyloarthritis
• Lupus

Bioinformatics and machine learning analysis

We combine public and proprietary datasets to provide high-quality leads and actionable insights. Our infrastructure includes high-performance computing clusters, optimized codes for large-scale analysis and proprietary algorithms for integrative machine learning and bioinformatics. ATI provides the following services:

• Multi-omics integration and predictive modeling
• Biological network and pathway analysis
• Decision support system development
• Machine learning and analytics on very large datasets
• Professional tool development and deployment of software-as-a-service (SaaS) to client corporate infrastructure

Specialty services

We provide expert opinion and analysis that is tailored to our client’s needs. Previous projects focused on candidate screening, lead identification and target validation, disease indication, drug repositioning, adverse event prediction, and strategy planning. The company and its founders have strong ties with machine learning and analytics companies, funding agencies, biopharmaceutical talent, venture funds, and academic institutions that provide a unique combination of trusted partners for research and development tailored to the specific needs of our clients.